ICUI - ICU Medical, Inc.
Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.
ICU Medical, Inc. (NASDAQ: ICUI - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nine analysts that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, four have given a buy rating and two have given a strong buy rating to
On September 22, 2026, ICU Medical Inc (ICUI) shares rose 3.7%, bringing the current price to $160.98. The stock has fluctuated within a 52-week range of $112.5
Ambu A/S (OTCMKTS:AMBBY - Get Free Report) and ICU Medical (NASDAQ: ICUI - Get Free Report) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends. Earnings and Valuation This table compares Ambu
The sale was part of a trading plan established in June.
Jushi (OTCMKTS:JUSHF - Get Free Report) and ICU Medical (NASDAQ: ICUI - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, valuation and dividends. Risk and Volatility Jushi has a beta of -0.63,
Bonnell retains 62,443 direct shares.
ICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
California State Teachers Retirement System boosted its holdings in shares of ICU Medical, Inc. (NASDAQ: ICUI) by 14,236.6% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,944,273 shares of the medical instruments supplier's stock after purchasing an additional 3,916,761 shares during
SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference on September 9-10, 2026 Company management will attend the Wells Fargo 21st Annual Healthcare Conference, held at the Encore Boston Harbor in Boston, MA, participating in one-on-one meetings on Wednesday, September 9 and Thursday, September 10, 2026.
BlackRock Inc. acquired a new position in shares of ICU Medical, Inc. (NASDAQ: ICUI) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,753,409 shares of the medical instruments supplier's stock, valued at approximately $550,250,000. BlackRock Inc. owned about 15.02% of ICU
Emerald Investment Advisers LLC acquired a new stake in ICU Medical, Inc. (NASDAQ: ICUI) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 25,314 shares of the medical instruments supplier's stock, valued at approximately $3,711,000. Emerald Investment Advisers LLC owned about 0.10%
California State Teachers Retirement System grew its stake in shares of ICU Medical, Inc. (NASDAQ: ICUI) by 25.2% during the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 27,512 shares of the medical instruments supplier's stock after purchasing an additional 5,536 shares during the period.
ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.
ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript
ICU Medical NASDAQ: ICUI reported second-quarter revenue of $548 million, up 6% organically and 1% on a reported basis, as growth in its consumables and infusion systems businesses helped offset continued pressure in Vital Care and the effects of the IV Solutions joint venture deconsolidation.
While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ICU Medical (ICUI) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $2.1 per share a year ago.
SAN CLEMENTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2026.
SAN CLEMENTE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2026 earnings release and conference call.